Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.08−0.00 (-3.04%)
Close on Nov 17, 2026Market cap $1.60MP/E –Yield –
Vivos Therapeutics cash
Cash and short-term investments held at the end of each period.
Vivos Therapeutics's cash was $1.77M at Jun 30, 2026. For fiscal 2025 it was $2.03M, down 67.6% from the year before. The highest annual figure on record is $24.03M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03M | -67.6% |
| FY2024 | Dec 31, 2024 | $6.26M | +281.0% |
| FY2023 | Dec 31, 2023 | $1.64M | -53.3% |
| FY2022 | Dec 31, 2022 | $3.52M | -85.4% |
| FY2021 | Dec 31, 2021 | $24.03M | +32.0% |
| FY2020 | Dec 31, 2020 | $18.21M | +3779.0% |
| FY2019 | Dec 31, 2019 | $469.35K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.77M | -59.7% |
| Q1 FY2026 | Mar 31, 2026 | $2.11M | -9.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.03M | -67.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.09M | -51.1% |
| Q2 FY2025 | Jun 30, 2025 | $4.40M | -36.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.34M | -10.3% |
| Q4 FY2024 | Dec 31, 2024 | $6.26M | +281.0% |
| Q3 FY2024 | Sep 30, 2024 | $6.31M | +538.8% |
| Q2 FY2024 | Jun 30, 2024 | $6.90M | +75.1% |
| Q1 FY2024 | Mar 31, 2024 | $2.61M | -62.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.64M | -53.3% |
| Q3 FY2023 | Sep 30, 2023 | $988.00K | -85.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.94M | -68.9% |
| Q1 FY2023 | Mar 31, 2023 | $7.05M | -60.5% |
| Q4 FY2022 | Dec 31, 2022 | $3.52M | -85.4% |
| Q3 FY2022 | Sep 30, 2022 | $6.72M | -76.5% |
| Q2 FY2022 | Jun 30, 2022 | $12.66M | -63.0% |
| Q1 FY2022 | Mar 31, 2022 | $17.83M | +26.8% |
| Q4 FY2021 | Dec 31, 2021 | $24.03M | +32.0% |
| Q3 FY2021 | Sep 30, 2021 | $28.53M | +5979.5% |
| Q2 FY2021 | Jun 30, 2021 | $34.20M | – |
| Q1 FY2021 | Mar 31, 2021 | $14.06M | – |
| Q4 FY2020 | Dec 31, 2020 | $18.21M | – |
| Q4 FY2019 | Dec 31, 2019 | $469.35K | – |
See a number that looks wrong?